ARCHIVES

NCI Outlines Need For $3,873 Billion To Seize Cancer Research Opportunities

This article is from The Cancer Letter archive.

Vol. 24 No. 41 | October 30, 1998

Download PDF Visit The Full Archive

Related Articles

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

October 22, 2004

Owens Becomes President, NCCR

June 21, 1996

NCI’s Hawk To Lead Prevention Division At M.D. Anderson.

November 16, 2007

Abraxane and Gemcitabine Improves Overall Survival

November 30, 2012

DeLap: Seven Years In industry Provided View Of Pressures On Drug Developers

August 2, 1996

NCI Separates Carcinogenesis Research Efforts

February 18, 1977